NB
Narayanasamy Balakrishnan
About Narayanasamy Balakrishnan
Data last updated:
Narayanasamy Balakrishnan has 24 years in corporate governance. Holds Director role. Currently with 2 companies, including Marksell Pharma Limited and El-Shaddai Biologicals Limited. Formerly with 1 company. Engaged in General Business, Healthcare. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 El-Shaddai Biologicals Limited U24232TN2004PLC054527 | Director | 02 Apr 2010 | 2004 | – | Active |
| Marksell Pharma Limited U24231TN1999PLC043491 | Director | 11 Oct 2001 | 1999 | – | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Marksell Healthcare Solutions Private Limited U52100TN2009PTC072741 | Director | 31 Aug 2009 | 2009 | – | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Narayanasamy Balakrishnan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Narayanasamy Balakrishnan
Narayanasamy Balakrishnan has 24 years in corporate governance. Holds Director role. Currently with 2 companies, including Marksell Pharma Limited and El-Shaddai Biologicals Limited. Formerly with 1 company. Engaged in General Business, Healthcare. Contributes to corporate operations.
Narayanasamy Balakrishnan is associated with 2 companies as Director, including El-Shaddai Biologicals Limited, Marksell Pharma Limited.
Narayanasamy Balakrishnan has expertise in General Business, Healthcare.
Narayanasamy Balakrishnan has 24 years in corporate governance.
Narayanasamy Balakrishnan currently holds positions at 2 companies: El-Shaddai Biologicals Limited, Marksell Pharma Limited.